119 related articles for article (PubMed ID: 20573508)
1. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
[TBL] [Abstract][Full Text] [Related]
2. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
[TBL] [Abstract][Full Text] [Related]
3. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
[TBL] [Abstract][Full Text] [Related]
5. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
[TBL] [Abstract][Full Text] [Related]
6. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.
Fox A; Kaur S; Li B; Panesar M; Saha U; Davis C; Dragoni I; Colley S; Ritchie T; Bevan S; Burgess G; McIntyre P
Br J Pharmacol; 2005 Apr; 144(7):889-99. PubMed ID: 15685199
[TBL] [Abstract][Full Text] [Related]
7. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
[TBL] [Abstract][Full Text] [Related]
8. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
[TBL] [Abstract][Full Text] [Related]
9. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
[TBL] [Abstract][Full Text] [Related]
10. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
[TBL] [Abstract][Full Text] [Related]
11. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.
Campos MM; Leal PC; Yunes RA; Calixto JB
Trends Pharmacol Sci; 2006 Dec; 27(12):646-51. PubMed ID: 17056130
[TBL] [Abstract][Full Text] [Related]
12. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
Chen JJ; Nguyen T; D'Amico DC; Qian W; Human J; Aya T; Biswas K; Fotsch C; Han N; Liu Q; Nishimura N; Peterkin TA; Yang K; Zhu J; Riahi BB; Hungate RW; Andersen NG; Colyer JT; Faul MM; Kamassah A; Wang J; Jona J; Kumar G; Johnson E; Askew BC
Bioorg Med Chem Lett; 2011 Jun; 21(11):3384-9. PubMed ID: 21514825
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Huang H; Player MR
J Med Chem; 2010 Aug; 53(15):5383-99. PubMed ID: 20369879
[No Abstract] [Full Text] [Related]
15. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.
Ritchie TJ; Dziadulewicz EK; Culshaw AJ; Müller W; Burgess GM; Bloomfield GC; Drake GS; Dunstan AR; Beattie D; Hughes GA; Ganju P; McIntyre P; Bevan SJ; Davis C; Yaqoob M
J Med Chem; 2004 Sep; 47(19):4642-4. PubMed ID: 15341478
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
[TBL] [Abstract][Full Text] [Related]
17. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.
Schaudt M; Locardi E; Zischinsky G; Stragies R; Pfeifer JR; Gibson C; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1225-8. PubMed ID: 20015645
[TBL] [Abstract][Full Text] [Related]
18. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
[TBL] [Abstract][Full Text] [Related]
19. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
